[
    {
        "utterance": "Tom Mansell: Sensing and regulation is a big part of the plan here. But for now, we're in the very preliminary stages of that. ",
        "annotations": {
            "explain or define term or concept": "The speaker is defining the scope of 'sensing and regulation' within the current plan.",
            "present new idea": "The speaker is introducing the idea that 'sensing and regulation' is a significant component of the plan."
        }
    },
    {
        "utterance": "Tanya Nguyen: To follow up on what you're saying and also what Jay had mentioned earlier, and I have no idea how to do this, but it would be so cool to develop a way to kind of individually determine what someone's microbiome is at homeostasis, their ideal kind of microbiome environment, whether that be composition, metabolites, chemicals, and then use that as a baseline, and then being able to develop, you know, these different chemically engineered bacteria then produce specific metabolites to keep that person at that specific ideal level or attain an ideal level for them to then minimize their clinical symptoms or functioning. I think that would be a really cool idea, no idea how to get there, but happy to talk about it further and develop that. ",
        "annotations": {
            "expand on existing idea": "Tanya is building upon what Tom and Jay mentioned earlier, indicating she is expanding on a previously discussed idea.",
            "present new idea": "Tanya introduces a novel concept of individually determining someone's ideal microbiome environment and using chemically engineered bacteria to maintain it, which is a new approach not previously discussed.",
            "express enthusiasm": "Tanya expresses excitement about the idea by saying \"it would be so cool\" and \"I think that would be a really cool idea.\""
        }
    },
    {
        "utterance": "Tom Mansell: I think you could do it with one molecule. I don't know about all of those. But you know, if it's short chain fatty acids, I think that that's a great idea. ",
        "annotations": {
            "expand on existing idea": "Tom builds on Tanya's idea of using chemically engineered bacteria to produce specific metabolites by suggesting focusing on one molecule, specifically short-chain fatty acids.",
            "express agreement": "Tom explicitly agrees with Tanya's idea by stating \"I think that's a great idea.\""
        }
    },
    {
        "utterance": "Tom Mansell: Right now, I think, in general, the approaches, well, let's just make more, make more given prebiotics, given probiotics that we think are going to make butyrate. But you know, there might, there's probably a level that's too high, right? ",
        "annotations": {
            "expand on existing idea": "Tom is expanding on Tanya's idea of chemically engineered bacteria by discussing current approaches to microbiome manipulation using prebiotics and probiotics.",
            "provide supporting evidence": "Tom supports his idea by mentioning that there might be a level of butyrate that is too high, implying that simply increasing production isn't always the best approach.",
            "express alternative decision": "Tom is suggesting an alternative to the current general approaches of simply increasing butyrate production, implying that there might be a level that's too high."
        }
    },
    {
        "utterance": "Tom Mansell: Do they take 12 different probiotic supplements every day to maintain that? You know, that's kind of the, yeah, so. ",
        "annotations": {
            "express humor": "Tom is making a joke about the impracticality of taking many supplements to maintain a microbiome, following up on the discussion about microbiome homeostasis and personalized treatments."
        }
    },
    {
        "utterance": "Tom Mansell: Yeah, no, that's a good idea. I mean, there is this whole, you know, what's a healthy microbiome, what's a healthy metabolome. That's, I think, going to vary by the host, and these host factors really influence these things, right? So, in addition to diet, of course, right? ",
        "annotations": {
            "express agreement": "Tom Mansell agrees with Tanya's idea of individually determining someone's microbiome at homeostasis and using chemically engineered bacteria to maintain that level.",
            "expand on existing idea": "Tom expands on the idea of a healthy microbiome and metabolome, adding that it varies by the host and is influenced by host factors and diet, building on Tanya's idea of individual microbiome baselines.",
            "explain or define term or concept": "Tom is explaining the concept of a healthy microbiome and metabolome, and how it varies by the host."
        }
    },
    {
        "utterance": "Tom Mansell: You can blame it on behavior a little bit, but also there's probably genetic factors too, right, that influence your microbiome. I'm just gabbling, yeah. ",
        "annotations": {
            "expand on existing idea": "Tom is expanding on the idea of host factors influencing the microbiome, which he mentioned in the previous utterance, by adding behavior and genetic factors as potential influences.",
            "provide supporting evidence": "Tom provides supporting evidence by suggesting that genetic factors influence the microbiome, building on the discussion of host factors and diet.",
            "explain or define term or concept": "Tom is explaining the concept of factors that influence the microbiome, including behavior and genetics, to provide a more comprehensive understanding."
        }
    },
    {
        "utterance": "Jae Sung: I guess we have many more questions than answers. That's because that's how science works. Very interesting. ",
        "annotations": [
            {
                "express frustration": "The phrase \"I guess we have many more questions than answers\" expresses frustration about the current state of the project, where there are more unknowns than knowns."
            },
            {
                "express humor": "The statement \"That's because that's how science works\" is a humorous way to acknowledge the inherent uncertainty and iterative nature of scientific research."
            },
            {
                "express enthusiasm": "The phrase \"Very interesting\" expresses enthusiasm about the topic being discussed."
            }
        ]
    },
    {
        "utterance": "Tom Mansell: I just have to say, as a chemical engineer, the thing that I have gotten most out of this discussion is this motility concept, right? And so we talked, you know, Emily framed the discussion as, this is a bioreactor, right? This is, we have a whole core curriculum on this on reactor design. ",
        "annotations": [
            {
                "acknowledge contribution": "Tom acknowledges that the motility concept is what he got most out of the discussion, recognizing Emily's framing of the discussion as a bioreactor."
            },
            {
                "expand on existing idea": "Tom expands on the bioreactor idea by mentioning that they have a whole core curriculum on reactor design, building on Emily's initial framing of the discussion."
            }
        ]
    },
    {
        "utterance": "Tom Mansell: A key parameter of reactor design is residence time, which is the flow rate divided by the volume, right? So, that motility, being the flow rate, is going to influence the conversion or whatever fermentation products come out of your reactor, right? And so, I love this idea of influencing motility as a way to manipulate the microbiome, and in doing so, manipulate the metabolome. ",
        "annotations": {
            "explain or define term or concept": "Tom defines residence time as flow rate divided by volume, which is a key parameter of reactor design, to provide clarity within the context of the discussion.",
            "expand on existing idea": "Tom builds on the motility concept, previously introduced, by explaining how it influences the conversion or fermentation products in the microbiome, linking it to reactor design principles.",
            "express enthusiasm": "Tom expresses his enthusiasm for the idea of influencing motility to manipulate the microbiome and metabolome, showing his excitement for this direction."
        }
    },
    {
        "utterance": "Faranak Fattahi: It's circular, and then it affects motility again. ",
        "annotations": [
            {
                "expand on existing idea": "Faranak is building on Tom's idea of motility influencing the microbiome and metabolome by adding that the effect is circular, further affecting motility."
            }
        ]
    },
    {
        "utterance": "Tom Mansell: Right. ",
        "annotations": {
            "express agreement": "Tom Mansell is agreeing with Faranak Fattahi's statement that the process is circular and affects motility again."
        }
    },
    {
        "utterance": "Tom Mansell: Yes, of course. And you know, like many processes, it probably is a small disruption that becomes non-linear, and then, you know, that's when you end up in a disease state. I don't know, I'm not that kind of doctor, but ",
        "annotations": [
            {
                "expand on existing idea": "Tom is expanding on the idea of the microbiome's influence on health, building on the previous discussion about factors affecting the microbiome and metabolome by adding that small disruptions can lead to non-linear effects and disease states."
            }
        ]
    },
    {
        "utterance": "Tom Mansell: So, Faranak, I think we should talk about your ENS essay a little more. ",
        "annotations": {
            "propose decision": "Tom Mansell suggests that the group should discuss Faranak's ENS essay further, proposing a concrete choice for the group."
        }
    },
    {
        "utterance": "Faranak Fattahi: Absolutely. Yeah, I'd love to. So we have actually done a lot of high throughput assays just looking at, you know, a library of neuroactive compounds. So these are around maybe 500 or 600 just small molecules that affect different neurotransmitter receptors. And turns out a lot of neurons in the GI tract respond to a variety of different neurotransmitter agonists and antagonists. And many of them could be influenced by microbial products. ",
        "annotations": [
            {
                "expand on existing idea": "Faranak is expanding on the discussion about the ENS essay that Tom suggested they talk about, providing details about the high throughput assays they have done."
            },
            {
                "provide supporting evidence": "Faranak provides supporting evidence for her work on ENS by mentioning the high throughput assays and the findings about neurons in the GI tract responding to neurotransmitters."
            }
        ]
    },
    {
        "utterance": "Emily Balskus: Okay, so we we probably have five minutes or so left, maybe um uh yeah, so thinking about and it looks like Jay Jay might have stepped away from his computer. Thinking about you sort of condensing and highlighting the key takeaways, um yeah, maybe Sarah. ",
        "annotations": [
            {
                "encourage particpatioin": "Emily is inviting Sarah to contribute by asking her to condense and highlight the key takeaways from the discussion."
            }
        ]
    },
    {
        "utterance": "Faranak Fattahi: I guess for me the the main takeaways are we have um so the field has identified many interesting correlations between um certain fermentation products and neurological disorders. Um and so we know that those actually are relevant to actual clinical data and in my mouse models. And so we are expanding, we are hoping to expand our knowledge of what other products might be important in like overall neurological. ",
        "annotations": {
            "provide supporting evidence": "Faranak states that the field has identified correlations between fermentation products and neurological disorders, and that these correlations are relevant to clinical data and her mouse models, thus providing supporting evidence for the importance of microbial products in neurological health, building on the prior discussion about the microbiome and metabolome."
        }
    },
    {
        "utterance": "Emily Balskus: Oh we really don't have yeah. ",
        "annotations": {
            "express frustration": "Emily expresses frustration that they don't have much time left in the meeting."
        }
    },
    {
        "utterance": "Faranak Fattahi: And then we want to know if um we can build models to then get at the mechanistic steps where basically these um these products then you know, induce all these changes in the body that then translate into effects on the disease. Um I guess another important point was the medications and how they um get affected by the microbiome and then vice versa, how like management of these patients affects the motility and the composition of the microbes. So yeah, I guess Jay's back so. ",
        "annotations": [
            {
                "expand on existing idea": "Faranak is building on the previous discussion about correlations between fermentation products and neurological disorders by stating the desire to build models to understand the mechanistic steps by which these products induce changes in the body that lead to disease."
            },
            {
                "present new idea": "Faranak introduces a new point about the medications and how they get affected by the microbiome and vice versa, which was not explicitly discussed before."
            }
        ]
    },
    {
        "utterance": "Emily Balskus: Thanks Jay. ",
        "annotations": {
            "acknowledge contribution": "Emily acknowledges Jay's return to the meeting, recognizing his participation."
        }
    },
    {
        "utterance": "Jae Sung: All right, I'm going to try to summarize all this to ",
        "annotations": {
            "present new idea": "Jae Sung is introducing the idea of summarizing the discussion, which is a new direction for the conversation at this point."
        }
    }
]